150 related articles for article (PubMed ID: 31350456)
21. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
[TBL] [Abstract][Full Text] [Related]
22. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development.
Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z
Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835
[TBL] [Abstract][Full Text] [Related]
23. Investigation of
Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
[TBL] [Abstract][Full Text] [Related]
24. Association of lncRNA
Wu ER; Hsieh MJ; Chiang WL; Hsueh KC; Yang SF; Su SC
Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31398859
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
[TBL] [Abstract][Full Text] [Related]
26. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z
Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
28. The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma.
Mo H; Wang X; Ji G; Liang X; Yang Y; Sun W; Jia X; Xu L; Qiao Y; Zhou H; Zhao W; Fu S; Zhang X
BMC Genomics; 2022 Nov; 23(1):769. PubMed ID: 36418931
[TBL] [Abstract][Full Text] [Related]
29. High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis.
Zhong DN; Luo YH; Mo WJ; Zhang X; Tan Z; Zhao N; Pang SM; Chen G; Rong MH; Tang W
Mol Med Rep; 2018 Jan; 17(1):1148-1156. PubMed ID: 29115524
[TBL] [Abstract][Full Text] [Related]
30. Associations of MALAT1 and its functional single nucleotide polymorphisms with cancer.
Cao L; Yan G; Yu S; Li F; Su Z; Hou X; Xiao J; Tian T
Pathol Res Pract; 2022 Aug; 236():153988. PubMed ID: 35759938
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
32. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
33. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA.
He J; Zuo Q; Hu B; Jin H; Wang C; Cheng Z; Deng X; Yang C; Ruan H; Yu C; Zhao F; Yao M; Fang J; Gu J; Zhou J; Fan J; Qin W; Yang XR; Wang H
Cancer Lett; 2019 May; 450():98-109. PubMed ID: 30790682
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
37. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
39. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
[TBL] [Abstract][Full Text] [Related]
40. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
